Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.

    Fauci AS, Gallo RC, Koenig S, Salk J, Purcell RH.

    Ann Intern Med. 1989 Mar 1;110(5):373-85. Review.PMID: 2464961 [PubMed - indexed for MEDLINE]Related articles

    2.

    Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.

    Nara PL, Robey WG, Arthur LO, Asher DM, Wolff AV, Gibbs CJ Jr, Gajdusek DC, Fischinger PJ.

    J Virol. 1987 Oct;61(10):3173-80.PMID: 2442411 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The development of an AIDS vaccine: progress and promise.

    Fauci AS, Fischinger PJ.

    Public Health Rep. 1988 May-Jun;103(3):230-6.PMID: 3131812 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.

    Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.

    Vaccine. 2001 Dec 12;20(5-6):813-25.PMID: 11738745 [PubMed - indexed for MEDLINE]Related articles

    5.

    Progress in HIV vaccine research.

    van der Ryst E.

    Oral Dis. 2002;8 Suppl 2:21-6. Review.PMID: 12164654 [PubMed - indexed for MEDLINE]Related articles

    6.

    Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

    Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O.

    Virology. 2001 Jan 5;279(1):241-56.PMID: 11145906 [PubMed - indexed for MEDLINE]Related articles

    7.

    Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees.

    Santra S, Fultz PN, Letvin NL.

    J Virol. 1999 Aug;73(8):7065-9.PMID: 10400811 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.

    Boyer JD, Wang B, Ugen KE, Agadjanyan M, Javadian A, Frost P, Dang K, Carrano RA, Ciccarelli R, Coney L, Williams WV, Weiner DB.

    J Med Primatol. 1996 Jun;25(3):242-50.PMID: 8892046 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cytotoxic T lymphocytes against HIV.

    Walker BD, Plata F.

    AIDS. 1990 Mar;4(3):177-84. Review.PMID: 1693514 [PubMed - indexed for MEDLINE]Related articles

    10.

    Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

    Girard M, Meignier B, Barré-Sinoussi F, Kieny MP, Matthews T, Muchmore E, Nara PL, Wei Q, Rimsky L, Weinhold K, et al.

    J Virol. 1995 Oct;69(10):6239-48.PMID: 7666524 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [AIDS vaccines: an enigma in vaccine development]

    Dorner F, Barrett N.

    Wien Klin Wochenschr. 1990 Jan 19;102(2):51-8. Review. German. PMID: 1689919 [PubMed - indexed for MEDLINE]Related articles

    12.

    Development and testing of AIDS vaccines.

    Koff WC, Hoth DF.

    Science. 1988 Jul 22;241(4864):426-32. Review.PMID: 3293212 [PubMed - indexed for MEDLINE]Related articles

    13.

    Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.

    Wagner R, Deml L, Schirmbeck R, Reimann J, Wolf H.

    Behring Inst Mitt. 1994 Dec;(95):23-34. Review.PMID: 7755506 [PubMed - indexed for MEDLINE]Related articles

    14.

    Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.

    Nara PL, Robey WG, Gonda MA, Carter SG, Fischinger PJ.

    Proc Natl Acad Sci U S A. 1987 Jun;84(11):3797-801.PMID: 3473484 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Development of HIV vaccines]

    Shibata R.

    Nippon Rinsho. 2002 Apr;60(4):790-7. Review. Japanese. PMID: 11968790 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

    Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.

    J Virol. 2005 Oct;79(19):12321-31.PMID: 16160159 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Development of artificial vaccines against HIV using defined epitopes.

    Berzofsky JA.

    FASEB J. 1991 Jul;5(10):2412-8. Review.PMID: 1712327 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Novel vaccines against M. tuberculosis]

    Okada M.

    Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese. PMID: 17240920 [PubMed - indexed for MEDLINE]Related articles

    19.

    The immune response to HIV: implications for vaccine development.

    Bolognesi DP.

    Semin Immunol. 1993 Jun;5(3):203-14. Review.PMID: 8347841 [PubMed - indexed for MEDLINE]Related articles

    20.

    Challenges in the search for an HIV vaccine.

    Lemckert AA, Goudsmit J, Barouch DH.

    Eur J Epidemiol. 2004;19(6):513-6. Review.PMID: 15330122 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data